Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaili Tapiavala

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The American Journal of Dermatopathology|February 16, 2022
Erythematous Nodule on the Upper Back: ChallengeShaili Tapiavala, Allie Preston, Palak Parekh
The American Journal of Dermatopathology|February 16, 2022
Erythematous Nodule on the Upper Back: AnswerShaili Tapiavala, Allie Preston, Palak Parekh
Frontiers in Oncology|August 29, 2025
Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitorsShaili Tapiavala, Chongliang Luo, Mina Shenouda, et al.
Annals of Surgical Oncology|July 14, 2025
Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast CancerShaili Tapiavala, Ying Liu, Shireen Roy, et al.
JAMA Network Open|February 26, 2025
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast CancerEmily L Podany, Lorenzo Foffano, Lorenzo Gerratana, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The American Journal of Dermatopathology|February 16, 2022
Erythematous Nodule on the Upper Back: ChallengeShaili Tapiavala, Allie Preston, Palak Parekh
The American Journal of Dermatopathology|February 16, 2022
Erythematous Nodule on the Upper Back: AnswerShaili Tapiavala, Allie Preston, Palak Parekh
Frontiers in Oncology|August 29, 2025
Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitorsShaili Tapiavala, Chongliang Luo, Mina Shenouda, et al.
Annals of Surgical Oncology|July 14, 2025
Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast CancerShaili Tapiavala, Ying Liu, Shireen Roy, et al.
JAMA Network Open|February 26, 2025
Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast CancerEmily L Podany, Lorenzo Foffano, Lorenzo Gerratana, et al.
Pageof 1